Peripheral Nerve Injuries Market Report 2026

Peripheral Nerve Injuries Market Overview

• Peripheral Nerve Injuries market size has reached to $4.41 billion in 2025 • Expected to grow to $7.65 billion in 2030 at a compound annual growth rate (CAGR) of 11.4% • Growth Driver: Rising Incidence Of Peripheral Nerve Injuries And Market Growth • Market Trend: Increased Public R&D Funding Driving Innovation in Peripheral Nerve Injury Therapeutics • North America was the largest region in 2025.

What Is Covered Under Peripheral Nerve Injuries Market?

Peripheral nerve injury refers to any damage or dysfunction that affects the peripheral nerves, which are the nerves outside the brain and spinal cord. These nerves are responsible for transmitting signals between the central nervous system (CNS) and the rest of the body, enabling sensation, movement, and motor coordination. The main product types of peripheral nerve injuries are nerve conduits, nerve protectors, nerve connectors, and nerve wraps. A nerve protector is a medical device or material used to shield and safeguard nerves from damage or injury during surgical procedures. The various injuries include traumatic injuries, compression injuries, and surgical injuries that are treated through various surgeries such as direct nerve repair, nerve grafting, and stem cell therapy. These are used in various applications such as upper extremities, and lower extremities and also by various end-users such as hospitals and clinics, rehabilitation centers, home care settings

What Is The Peripheral Nerve Injuries Market Growth Forecast?

The peripheral nerve injuries market size is expected to see rapid growth in the next few years. It will grow to $7.65 billion in 2030 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to growing adoption of stem cell-assisted nerve repair, rising investments in regenerative medicine research, expansion of advanced biomaterial usage, increasing demand for minimally invasive nerve repair, growing focus on long-term functional recovery. Major trends in the forecast period include increasing use of bioabsorbable nerve repair products, rising adoption of advanced nerve conduits and wraps, growing integration of regenerative medicine approaches, expansion of microsurgical nerve repair techniques, enhanced focus on functional recovery outcomes.

Global Peripheral Nerve Injuries Market Segmentation

1) By Product: Nerve Conduit, Nerve Protector, Nerve Connector, Nerve Wraps 2) By Injury: Traumatic Injuries, Compression Injuries, Surgical Injuries 3) By Surgery: Direct Nerve Repair, Nerve Grafting 4) By Application: Upper Extremities, Lower Extremities 5) By End-User: Hospitals And Clinics, Rehabilitation Centers, Home Care Settings Subsegments: 1) By Nerve Conduit: Collagen Nerve Conduits, Silicone Nerve Conduits, Polymeric Nerve Conduits 2) By Nerve Protector: Nerve Guarding Agents, Nerve Protecting Gel And Films 3) By Nerve Connector: Nerve Suture Connectors, Nerve Stitching Connectors 4) By Nerve Wraps: Collagen Nerve Wraps, Tubular Nerve Wraps, Bioabsorbable Nerve Wraps

What Are The Drivers Of The Peripheral Nerve Injuries Market?

The increasing incidence of accidents is expected to propel the growth of the peripheral nerve injuries market going forward. The increasing incidence of accidents can be attributed to a combination of factors, including changes in urbanization which lead to higher traffic volumes, lifestyle, environmental conditions, and distracted behaviors. Peripheral nerve injuries often necessitate comprehensive treatment strategies to mitigate their impact and facilitate recovery. Investigational treatments such as stem cell therapy, growth factor administration, or gene therapy may hold promise for enhancing nerve regeneration and functional recovery for patients injured due to accidents. For instance, In August 2025, according to the International Transport Forum, a France-based intergovernmental organization, in 2024, Australia recorded 1,297 road deaths, marking a 4% increase compared to 2023. Therefore, the increasing incidence of accidents is driving the growth of the peripheral nerve injuries industry. The increasing minimally invasive surgeries is expected to propel the growth of the peripheral nerve injuries market going forward. Minimally invasive surgeries refer to medical procedures that involve small incisions, specialized tools, and advanced imaging techniques to minimize patient recovery time, pain, and the risk of complications. The increasing adoption of minimally invasive surgeries can be attributed to several factors, including reduced recovery time, lower risk of complications, and improved patient outcomes. Peripheral nerve injuries require precise, targeted approaches to avoid damage to surrounding tissues, driving the development of advanced surgical tools such as robotic systems, endoscopic instruments, and precision-guided technologies, which enable more accurate interventions with minimal incisions, reducing the risk of nerve damage and improving recovery times. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, minimally invasive procedures increased by 7% in 2023, outpacing the growth rate of surgical procedures by 2%. Hand surgeries such as carpal tunnel, arthritis, and trigger finger totaled 207,887 procedures, a 2% rise from 2022. Therefore, the increasing adoption of minimally invasive surgeries is driving the growth of the peripheral nerve injuries industry.

Key Players In The Global Peripheral Nerve Injuries Market

Major companies operating in the peripheral nerve injuries market are Medtronic Plc, Stryker Corporation, Integra LifeSciences Holdings Corp., Bioventus LLC, MicroPort Scientific Corporation, AxoGen Inc., Bioness Inc., SPR Therapeutics Inc., NeuroMetrix Inc., Polyganics BV, Regenity Biosciences, Renerva LLC, Neuraptive Therapeutics Inc., Neuros Medical Inc., Synapse Biomedical Inc., Orthocell Ltd., NeuraLace Medical Inc., Epineuron LLC, Checkpoint Surgical Inc., Collagen Matrix Inc.

Global Peripheral Nerve Injuries Market Trends and Insights

Major companies operating in the peripheral nerve injuries market are focusing on developing innovative solutions, such as resorbable soft-tissue barrier allografts, to enhance nerve protection and improve surgical healing outcomes. These allografts act as temporary physical barriers that prevent adhesions and soft-tissue attachments during the critical early phase of nerve repair, offering advantages over traditional methods like synthetic wraps or no coverage, which often lead to scarring, tethering, or compromised nerve gliding. For instance, in June 2024, Axogen Inc., a US-based biotechnology company, launched Avive+ Soft Tissue Matrix, a resorbable, multi-layer amniotic membrane allograft intended to provide temporary protection and tissue separation during the early stages of peripheral nerve healing. Avive+ is composed of a multi-layer placental (amniotic) membrane, processed in compliance with FDA HCT/P regulations (21 CFR Part 1271), and is designed to remain in place for up to 16 weeks, offering robust handling, suturability, and a strong barrier function while preserving the natural properties of the amniotic tissue. Its applications include acutely traumatized nerves, crushed (non-transected) injuries, and surgical settings where soft-tissue protection is critical.

Regional Outlook

North America was the largest region in the peripheral nerve injuries market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Peripheral Nerve Injuries Market?

The peripheral nerve injuries market consists of sales of nerve injury medications, gene therapies, and stem cell therapy. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.